• Cortexia

  Participated · Equity · Dec 2023

  Cortexia SA develops AI-based technology for the environmental sector, operating a platform already deployed for urban cleanliness management. Its combined software-and-hardware solution is designed to measurably improve cleaning services, reduce resource use and lower environmental impact. Reference customers include the cities of Basel, Geneva, GPSO (Grand Paris Seine Ouest), Bordeaux, Strasbourg, Frankfurt and Hamburg, as well as companies such as Veolia and Suez. The company is extending its platform into broader waste management and received Swiss Accelerator support from Innosuisse earlier this year for a bio-waste recycling improvement solution. Cortexia is pursuing international expansion across Europe, including the Benelux, and has launched an "Alliance for the improvement of bio-waste quality" involving key Swiss sector players. To support growth and new application development it completed an oversubscribed CHF 2.35 million financing round.

• Bionomous

  Participated · Series A · Jan 2023

  Bionomous builds the EggSorter, an automated screening and sorting device for small biological entities (zebrafish eggs, Xenopus oocytes and embryos, plant seeds and more). The EggSorter uses a rotary wheel to present individual entities to a camera for bright-field or fluorescence imaging, then processes images and dispenses items into output containers based on classification. The device obtained CE certification in December 2022 and the company has entered a commercialization phase with customers lined up in Europe, the US and China. In January 2023 Bionomous raised USD 2.7 million in a Series A to scale production and prepare for global deployment. The funds will be used for product roll-out, US business development and to develop new industry-focused verticals. The startup was founded in 2019 and previously won CHF 150,000 from Venture Kick in 2020 and participated in the Venture Leaders Biotech roadshow in Boston in 2022. Bionomous is a Swiss biorobotics startup that makes the EggSorter, a device to automatically inspect, sort and dispense small biological entities like zebrafish eggs for life‑sciences research. The EggSorter aims to standardize laboratory workflows and increase research throughput for applications including drug discovery and toxicology testing. The company combines mechatronics, microfluidics and machine learning in its product and has attracted interest from leaders in the zebrafish field. Bionomous reports early traction, including confirmed orders received despite the COVID pandemic, and interest from early adopters. The recent CHF 1.3 million seed raise will fund acceleration of testing, development of a certified ready‑for‑market product and preparation for industrialization. The team also plans to explore applying the technology to other segments such as personalized medicine, diagnostics and aquaculture.

• Mobbot

  Participated · Seed · Jun 2020

  Mobbot offers a mobile robotic and automation platform that prints concrete infrastructure directly at the final location, producing items such as cable chambers, retaining walls and beams. Its 3D‑concrete printing approach can produce parts up to twenty times faster and at forty percent lower cost than traditional fabrication, while cutting material waste and CO2 emissions by up to thirty percent. The company has demonstrated operational traction, delivering 40 concrete products to clients in a single day. Mobbot’s technology centers on a patented mobile robot and the startup plans to accelerate development and commercialization of that platform. The recently closed financing will support R&D and continuous product innovation as well as strengthen the marketing and sales organization. Agnès Petit is CEO and Founder; the company has also highlighted Thomas Ribeaud as CTO.

No current team members are available.